New search | Conferencedetail
Print view
 
 

Antigen- Specific Immune Tolerance Drug Development Summit

evvnt Platform / evvnt
Conference themes
As the first generation of antigen-specific immune tolerance therapies enter clinics and with excitement around recent partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to be able to meet and share knowledge.
Professional congress organizer (PCO)
Hanson Wade
 

Enquiries and Registration:

https://go.evvnt.com/187943-2?pid=4832
Mr. Jamie Hill
 
Categories
Health Services
Languages
English
Congress fees
USD 3.797,00
(USD 2199 - USD 3797)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Helix - Forschung & Beratung WienÖsterreichisches Rotes KreuzAMREF - African Medical and Research FoundationCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHilfswerk AustrianewTreeÖsterreichische Gesellschaft für Public HealthEuropean Public Health Association (EUPHA)

Facebook

Give us your professional opinion

Start survey

Start survey